Henry Schein, Inc.

Equities

HSIC

US8064071025

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-12 pm EST			5-day change	1st Jan Change
76.13 ^USD	-1.94%		-3.07%	+0.73%

Jan. 12	Henry Schein, Inc. Appoints Frederick M. Lowery as Chief Executive Officer, Effective March 2, 2026	CI
Jan. 12	Henry Schein Names Frederick Lowery Chief Executive Officer	MT

Transcript : Henry Schein, Inc., Q3 2025 Earnings Call, Nov 04, 2025

Published on 11/04/2025 at 10:23 am EST - Modified on 11/25/2025 at 02:53 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Henry Schein, Inc.

Jan. 12	Henry Schein, Inc. Appoints Frederick M. Lowery as Chief Executive Officer, Effective March 2, 2026	CI
Jan. 12	Henry Schein Names Frederick Lowery Chief Executive Officer	MT
Jan. 12	Henry Schein Names Frederick Lowery Chief Executive	DJ
Dec. 23	Henry Schein Says it Expects to Name Next CEO by Mid-January 2026	MT
Dec. 23	Henry Schein amends private shelf agreement with PGIM - SEC filing	RE
Dec. 09	Barclays Initiates Henry Schein With Overweight Rating, $86 Price Target	MT
Dec. 02	Henry Schein, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 09:00 AM
Dec. 01	Henry Schein Becomes Exclusive US Distributor of vVARDIS' Curodont Treatment in January	MT
Dec. 01	Henry Schein, Inc. Expands Partnership with Vvardis	CI
Nov. 25	Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly	CI
Nov. 18	Henry Schein, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 02:30 PM
Nov. 12	Henry Schein, Inc. Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11:20 AM
Nov. 05	VideaHealth and Henry Schein One Launch the Impact Panel, Bringing AI-Driven Patient Education to Dentrix and Dentrix Ascend	CI
Nov. 05	JPMorgan Adjusts Price Target on Henry Schein to $78 From $80, Maintains Overweight Rating	MT
Nov. 05	Morgan Stanley Adjusts Price Target on Henry Schein to $58 From $55, Maintains Underweight Rating	MT
Nov. 05	Baird Adjusts Price Target on Henry Schein to $78 From $72, Maintains Neutral Rating	MT
Nov. 05	Stifel Adjusts Price Target on Henry Schein to $72 From $70, Maintains Neutral Rating	MT
Nov. 05	Evercore ISI Adjusts Price Target on Henry Schein to $90 From $83, Maintains Outperform Rating	MT
Nov. 04	Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018.	CI
Nov. 04	Wall St falls after big banks' CEOs warn of market downturn; Palantir slides	RE
Nov. 04	Henry Schein, Inc. Raises Earnings Guidance for the Year 2025	CI
Nov. 04	Henry Schein, Inc., Q3 2025 Earnings Call, Nov 04, 2025
Nov. 04	Henry Schein, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 27, 2025	CI
Nov. 04	Henry Schein lifts annual forecast on strong dental, medical equipment sales	RE
Nov. 04	MORNING BID AMERICAS-Nerves rising about frothy valuations	RE